SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,983 | -11.7% | 21,472 | -3.8% | 0.09% | -5.5% |
| Q2 2023 | $670,609 | -17.0% | 22,309 | 0.0% | 0.09% | -38.1% |
| Q1 2023 | $808,255 | +1.6% | 22,309 | 0.0% | 0.15% | -3.3% |
| Q4 2022 | $795,762 | -6.5% | 22,309 | +4.5% | 0.15% | +23.6% |
| Q4 2017 | $851,000 | -0.4% | 21,344 | 0.0% | 0.12% | -3.1% |
| Q3 2017 | $854,000 | -7.2% | 21,344 | 0.0% | 0.13% | -67.7% |
| Q2 2017 | $920,000 | +1252.9% | 21,344 | +888.6% | 0.39% | +379.3% |
| Q1 2017 | $68,000 | -99.9% | 2,159 | 0.0% | 0.08% | -91.7% |
| Q4 2016 | $54,514,000 | – | 2,159 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |